Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BioXesin is a line of biocompatible ophthalmic medical devices developed and manufactured by Omisan Farmaceutici. These products are primarily used as over-the-counter (OTC) eye drops and contact lens care solutions. BioXesin is formulated to provide symptomatic relief for ocular irritation, redness, and dryness by supplementing the natural tear film and providing physical lubrication to the ocular surface. As a biocompatible solution, it is designed to be gentle on sensitive eyes and is frequently utilized for the cleaning, rinsing, and hydration of contact lenses. The formulation typically includes isotonic buffering agents and may contain lubricants such as hypromellose or sodium hyaluronate, along with mild preservatives like polyhexamethylene biguanide (PHMB) and EDTA to ensure sterility and safety for long-term use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BioXesin.